Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 7/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.31 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28300974 | 0.87 | TBXAS1 (0.36) | TBXAS1ALDH1A1PDE3BPDE3AEGLN3 | |
| SCHEMBL6343791 | 0.73 | TBXAS1 (0.44) | TBXAS1ALDH1A1EGLN3 | |
| SCHEMBL7827324 | 0.73 | TBXAS1 (0.44) | TBXAS1ALDH1A1EGLN3 | |
| SCHEMBL7603750 | 0.72 | — | — | |
| SCHEMBL7603748 | 0.72 | — | — | |
| SCHEMBL28774624 | 0.72 | TBXAS1 (0.36) | TBXAS1ALDH1A1PDE3BPDE3AEGLN3 | |
| Acrylamide SCHEMBL3413886 | 0.70 | ALDH1A1 (0.42) | TBXAS1ALDH1A1EGLN3 | |
| SCHEMBL17278171 | 0.70 | TBXAS1 (0.31) | TBXAS1PDE3BPDE3A | |
| SCHEMBL27697140 | 0.68 | NFE2L2 (0.44) | TBXAS1ALDH1A1 | |
| SCHEMBL3947319 | 0.68 | HTT (0.34) | TBXAS1ALDH1A1PDE3BPDE3AEGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210219545-A1 | COMPOSITIONS AND METHODS FOR LONG LASTING DISINFECTION | RHODIA OPERATIONS (FR) | 2021-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210219545-A1 | COMPOSITIONS AND METHODS FOR LONG LASTING DISINFECTION | DNMT3A, RAD51, POLL | TBXAS1 4080/4885ALDH1A1 890/4885PDE3B 3447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.